Wednesday, May 14, 2025 5/14/2025

A Bayesian Meta-Analysis Approach for Estimation of Penetrance and its Application to PALB2 gene for Breast Cancer Risk

Award Number: R03CA242562
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

A Bayesian Meta-Analysis Approach for Estimation of Penetrance and its Application to PALB2 gene for Breast Cancer Risk - Project Abstract Due to the rapid drop in the cost of DNA sequencing, a panel of multiple (25 to 125) cancer susceptibility genes can be now tested at a fraction of cost and time of what was needed earlier for testing only a handful of well-known cancer genes such as BRCA1 and BRCA2. As multi-gene panel tests are becoming accessible to increasingly broader population, more and more patients carrying pathogenic germline mutations of various genes are being identiﬁed. This trend is creating a major paradigm shift in hereditary cancer risk assessment because the newly identiﬁed mutation carriers need advise about approporiate management strategies such as targeted surveillance and preventive options. The counseling hinges crucially on accurate quantitative estimates of age-speciﬁc risks of developing cancers associated with a speciﬁc gene whose pathogenic mutation a patient carries, i.e., penetrance estimates. For several gene-cancer associations, a substantial amount of literature on risk estimation is available and new studies are also becoming available at a fast pace. Yet a synthesis of evidence from all relevant studies in the form of a robust meta-analysis of penetrance is generally lacking. A case in point is PALB2-breast cancer association for which several studies report risk measures, however, there is no meta- analysis of penetrance estimates. Thus there is an urgent need for meta-analysis of penetrances so that mutation carriers in PALB2 and many other genes can be counseled appropriately in light of their age-speciﬁc risks of developing various cancers. A major challenge in this task is that studies typically vary in design (e.g., family- or population-based) and hence type of risk measures reported (e.g., penetrance, relative risk, or odds ratio). Synthesis of such heterogeneous risk measures is not possible using the standard meta-analysis approaches. Moreover, for an accurate and robust estimation, the meta-analysis model should properly take into account various sources of uncertainties that arise in such kind of synthesis. To ﬁll this gap, we propose a Bayesian hiererchical model for meta-analysis as it allows seamless integration of results of different types by borrowing information across the studies. At the same time, it accounts for uncertainties in a formal manner through hierarchical priors. Our ﬁrst speciﬁc aim is to develop this Bayesian meta-analysis methodology, investigate its properties, and compare it with existing approaches through simulations. The next speciﬁc aim is to apply this method to estimate the penetrance for PALB2 gene for breast cancer. Our ﬁnal aim is to develop an R package that implements the proposed Bayesian methodology and integrate it into the clinical decision support tool ASK2ME for immediate clinical use.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$135 )
2024	2021	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Cancer Cause and Prevention Research	000	2	7/3/2024	NON-COMPETING CONTINUATION	-$135
														Subtotal = -$135

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	UNIVERSITY OF TEXAS AT DALLAS	800 WEST CAMPBELL RD.	RICHARDSON	TX	75080	DALLAS	USA	Cancer Cause and Prevention Research	000	2	2/21/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $82,329 )
2021	2021	UNIVERSITY OF TEXAS AT DALLAS	800 W CAMPBELL RD	RICHARDSON	TX	75080	DALLAS	USA	Cancer Cause and Prevention Research	000	2	2/8/2021	NON-COMPETING CONTINUATION	$82,329
														Subtotal = $82,329

Issue Date FY: 2020 ( Subtotal = $82,161 )
2020	2020	UNIVERSITY OF TEXAS AT DALLAS	800 W CAMPBELL RD	RICHARDSON	TX	75080	DALLAS	USA	Cancer Cause and Prevention Research	000	1	3/6/2020	NEW	$82,161
														Subtotal = $82,161

Grand Total All Awards = $164,355

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Bayesian Meta-Analysis Approach for Estimation of Penetrance and its Application to PALB2 gene for Breast Cancer Risk

Award Number: R03CA242562

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer